Lindsay Deneault, MBA
Lindsay Deneault leads New Ventures and Strategic Industry Partnerships for Advocate Health, working with corporate and innovation ecosystems on strategic business ventures, co-development opportunities, and industry partnerships. Lindsay joined Atrium Health, now a part of Advocate Health, in 2016 to commercialize technology enabled products by collaborating with teammate inventors and to drive execution of enterprise strategic priorities by partnering with emerging and high growth companies. Examples include Atrium Health’s first therapeutic spinout, MLBio Solutions, to develop new therapies for patients with muscular dystrophy; venture investment into startup Xealth to scale consumer facing digital therapeutics across the enterprise; partnership with Siemens Healthineers on workforce development and environmental sustainability initiatives; partnership with Best Buy Health to co-develop the care at home ecosystem; and the CancerX public private partnership to boost innovation in the fight against cancer as part of the reignited Cancer Moonshot.
Prior to joining Atrium Health, she was a business strategist for the Texas Medical Center in Houston where she was responsible for launching the TMC Innovation Factory and managing the TMCx accelerator program to help TMC’s 21 member health systems spin out early stage technology companies and source startups to solve system needs. Lindsay has a bachelor’s degree in biomedical engineering from Virginia Commonwealth University and a master’s in business administration from Rice University.
She represents Advocate Health in the Academy’s Strategic Partnership Alliance, currently serves as a board advisor for Xealth, has served on the governance committee for the Strategic Ventures Group consortium of health system venture funds, and provides thought leadership and mentorship as an advisor for several health innovation groups and conferences, including the NC Biotechnology Center and SXSW.